Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?

Liver Int. 2016 Nov;36(11):1715. doi: 10.1111/liv.13208. Epub 2016 Aug 9.

Authors

Ying-Yang Liao¹, Jian-Hong Zhong¹, Ning-Fu Peng¹, Le-Qun Li¹, Tie-Jun Tong²

Affiliations

¹ Department of Oncology Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
² Department of Mathematics, Hong Kong Baptist University, Hong Kong, Hong Kong.

PMID: 27454762
DOI: 10.1111/liv.13208

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Hepatocellular*
Humans
Liver Neoplasms
Niacinamide / analogs & derivatives
Phenylurea Compounds
Portal Vein*
Sorafenib

Substances

Phenylurea Compounds
Niacinamide
Sorafenib